Credit Designation

Physicians' Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC designates this live activity for a maximum of 6.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Acknowledgment of Commercial Support

This activity is supported by educational grants from AstraZeneca, Boehringer Ingelheim Pharmaceuticals, Inc., Bristol-Myers Squibb, Celgene Corporation, Clovis Oncology, Genentech, Lilly, Merck, Inc., and Novartis Oncology.

For further information concerning Lilly grant funding visit www.lillygrantoffice.com.

9th Annual New York Lung Cancer Symposium®

9th Annual New York Lung Cancer Symposium®


This annual meeting will provide an update on advances in the current management of lung cancer, as well as a focus on the future.
Participants will have an opportunity to learn from engaging presentations delivered by leading experts.  Sessions will include emerging data, discussions on evolving standards of care, tumor board style case reviews and information that has the potential to impact their practice in the short term.  
Faculty will discuss key clinical topics, including:
  • Optimal use of EGFR/ALK TKIs
  • Best practices in the treatment of advanced stage lung cancers
  • Patient management across multiple lines of therapy
  • Tailored therapy for individual patient
  • Immunotherapies

Target Audience

This educational activity is directed toward medical oncologists, radiation oncologists, thoracic surgeons, pulmonologists involved in the treatment and management of patients with lung cancer.  Fellows, nurse practitioners, nurses, physician assistants, pharmacists, researchers, and other health care professionals interested in the treatment of lung cancer may also participate.

Program Chairs

Mark G. Kris, MD
Attending, Thoracic Oncology Service
William and Joy Ruane Chair in Thoracic Oncology
Memorial Sloan Kettering Cancer Center
New York, NY

Roman Perez-Soler, MD
Chairman, Department of Oncology
Montefiore Medical Center
Professor of Medicine and Molecular Pharmacology
Deputy Cancer Center Director
Albert Einstein College of Medicine
Bronx, NY

Disclosure Policy and Resolution of Conflicts of Interest (COI)

It is the policy of PER® to ensure balance, independence, objectivity, and scientific rigor in all of its educational activities. In accordance with the ACCME Standards for Commercial SupportSM, PER® requires everyone who is in a position to control the content of an educational activity, including spouses/partners, to disclose all relevant financial relationships with any commercial interest. PER® has implemented mechanisms to identify and resolve all conflicts of interest prior to start of each activity. Participants are notified prior to the activity of the presence or absence of relevant financial relationships between faculty and commercial interests. Information disclosed includes the name of the faculty, nature of the relevant financial relationship (e.g., member of speaker's bureau, grant/research support, or consulting arrangement), and the name of the company/organization with which the relationship exists. Additionally, prior to the start of each activity PER® discloses the source of commercial support to the participants.

Faculty, Staff, and Planners’ Disclosures

The following individuals have no relevant financial relationships with commercial interests to disclose:

Maria E. Arcila, MD; Abraham Chachoua, MD; Jamie E. Chaft, MD; Jorge E. Gomez, MD; Jeffrey G. Schneider, MD.

The staff of PER®, LLC: Debbie Augustus; Leigh Anne Bongiovanni; Tiffany Fattizzi; Ann C. Lichti, CCMEP; and David Lee, PhD.

The following individuals have relevant financial relationships with commercial interests to disclose:

Richard J. Gralla, MD -- Grant/Research Support: NIH/NCI; Consultant: Merck, Eisai; Balazs Halmos, MD -- Grant/Research Support: Astra-Zeneca, Boehringer-Ingelheim, Pfizer, Dekkun, Daiichi-Sankyo, Eli Lilly, Bristol-Myers Squibb, Incyte, Merck, Roche, Novartis, Astex; Peter Hammerman, MD, PhD -- Consultant: Astra-Zeneca, Janssen, ImClone, Ariad; Stock/Shareholder: Pfizer; Christine L. Hann, MD, PhD -- Grant-Research Support: GlaxoSmithKline; Harry D. Harper, MD -- Speaker's Bureau: Eli Lilly, Boehringer-Ingelheim; Roy S. Herbst, MD, PhD -- Consultant: SAB, Kolltan, N-of-One, Inc., DiaTech Oncology, Quintiles Inc., Biothera; Mark G. Kris, MD -- Grant/Research Support: Puma Biotechnology, Pfizer; Consultant: AstraZeneca, Threshold, Array; Benjamin P. Levy, MD -- Consultant: Genentech, Eli Lilly, Pfizer, Biodesix, Boehringer Ingelheim, Celgene; Speaker's Bureau: Genentech , Eli Lilly; Thomas J. Lynch, Jr., MD -- Honoraria/Stock/Board of Directors: Bristol-Myers Squibb; Honoraria/Stock/Scientific Advisory Board: Arvinas; Stock/Stockholder: Infinity Pharmaceutials; Royalties/Patent Holder: Partners Healthcare EGFR mutation testing patent; Roman Perez-Soler, MD -- Consultant: Certex, Clovis, Teva, Boehringer-Ingelheim; Harry Raftopoulos, MD -- Grant/Research Support: Novartis, Roche, Pfizer; Consultant: Merck; Gregory Riely, MD, PhD -- Grant/Research Support: Novartis, Pfizer, Infinity, GSK, Millennium; Consultant: Novartis; Bryan J. Schneider, MD -- Grant/Research Support: Celgene, Lilly; Consultant: Genentech; Speaker's Bureau: Genentech; Steven E. Vogl, MD -- Consultant/Advisory Board: Janssen; Stock/Shareholder: Amgen, Bristol-Myers Squibb.

Off-Label Disclosure and Disclaimer

This CME activity may or may not discuss investigational, unapproved, or off-label use of drugs. Participants are advised to consult prescribing information for any products discussed. The information provided in this CME activity is for continuing medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options for a specific patient's medical condition.

The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER®.

Physician Payments Sunshine Act

Physicians' Education Resource®, LLC, complies with the Physician Payments Sunshine Act as part of the Affordable Care Act (ACA). Accordingly, we may be required to collect information on transfers of value provided to any covered recipient under the ACA.

The Symposium is jointly provided by the Icahn School of Medicine at Mount Sinai and The Chemotherapy Foundation a non-profit organization supporting cancer research.

The Symposium is a multi-specialty cancer conference bringing advances in treatment that meet the learning needs of practicing oncologists in academia and community medicine while providing unique applications of electronic enhancements to a medical education activity.

For more information, visit: http://www.chemotherapyfoundationsymposium.org


You must be logged in to PER to register for this meeting

Or Register for PER now

*Required Fields

Login Information

Registration Information

In case of onsite emergency:

Professional Information


Calendar of Events
Filter By